12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Procoralan ivabradine regulatory update

EMA's CHMP issued a positive opinion to expand the label of ivabradine to include treatment of chronic heart failure. The drug is already marketed in...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >